Cardiovascular effects of salvianolic acid B

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Wang, Jie ^a   Xiong, Xingjiang ^a   Feng, Bo ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CD86 ANTIGEN; GELATINASE B; HLA DR ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N ACETYLGLUCOSAMINE; PHOSPHATIDYLINOSITIDE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SALVIANOLIC ACID B; STAT1 PROTEIN; T6 ANTIGEN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANGIOGENESIS; ANTICOAGULATION; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; ASIAN; ATHEROSCLEROSIS; BLOOD RHEOLOGY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; CELL MIGRATION; CELL PROLIFERATION; COLLAGEN SYNTHESIS; DENDRITIC CELL; ENDOTHELIUM CELL; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE REMODELING; HUMAN; IN VITRO STUDY; IN VIVO STUDY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SALVIA MILTIORRHIZA; SIGNAL TRANSDUCTION; UPREGULATION; VASCULAR DISEASE;

EID: 84879335837     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/247948     Document Type: Article

References (99)

1. Zhou L., Zuo Z., Chow M. S. S., Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. Journal of Clinical Pharmacology 2005 45 12 1345 1359 2-s2.0-27844511101 10.1177/0091270005282630
2. Wu B., Liu M., Zhang S., Dan shen agents for acute ischaemic stroke. Cochrane Database of Systematic Reviews 2007 18 2 CD004295 2-s2.0-34447305533
3. Wang C., Zhao X., Mao S., Wang Y., Cui X., Pu Y., Management of SAH with traditional Chinese medicine in China. Neurological Research 2006 28 4 436 444 2-s2.0-33745669086 10.1179/016164106X115044
4. Oda M., Yokomori H., Han J. Y., Regulatory mechanisms of hepatic microcirculatory hemodynamics: hepatic arterial system. Clinical Hemorheology and Microcirculation 2006 34 1-2 11 26 2-s2.0-33644790244
5. Horie Y., Han J. Y., Mori S., Konishi M., Kajihara M., Kaneko T., Yamagishi Y., Kato S., Ishii H., Hibi T., Herbal cardiotonic pills prevent gut ischemia/reperfusion-induced hepatic microvascular dysfunction in rats fed ethanol chronically. World Journal of Gastroenterology 2005 11 4 511 515 2-s2.0-19944430199
6. Xing H. C., Li L. J., Xu K. J., Shen T., Chen Y. B., Chen Y., Fu S. Z., Sheng J. F., Chen C. L., Wang J. G., Yan D., Dai F. W., Sha X. Y., Effects of Salvia miltiorrhiza on intestinal microflora in rats with ischemia/reperfusion liver injury. Hepatobiliary and Pancreatic Diseases International 2005 4 2 274 280 2-s2.0-20344394656
7. Chen C. G., Wang Y. P., Magnesium lithospermate B ameliorates renal cortical microperfusion in rats. Acta Pharmacologica Sinica 2006 27 2 217 222 2-s2.0-31644447525 10.1111/j.1745-7254.2006.00225.x
8. Hoffmann S. C., Kampen R. L., Amur S., Sharaf M. A., Kleiner D. E., Hunter K., John Swanson S., Hale D. A., Mannon R. B., Blair P. J., Kirk A. D., Molecular and immunohistochemical characterization of the onset and resolution of human renal allograft ischemia-reperfusion injury. Transplantation 2002 74 7 916 923 2-s2.0-0037108993
9. Bando Y., Tsukamoto Y., Katayama T., Ozawa K., Kitao Y., Hori O., Stern D. M., Yamauchi A., Ogawa S., ORP150/HSP12A protects renal tubular epithelium from ischemia-induced cell death. FASEB Journal 2004 18 12 1401 1403 2-s2.0-9444268084 10.1096/fj.03-1161fje
10. Chen Y., Ruan Y., Li L., Chu Y., Xu X., Wang Q., Zhou X., Effects of Salvia miltiorrhiza extracts on rat hypoxic pulmonary hypertension, heme oxygenase-1 and nitric oxide synthase. Chinese Medical Journal 2003 116 5 757 760 2-s2.0-0038171304
11. Reignier J., Sellak H., Lemoine R., Lubineau A., Mazmanian G. M., Detruit H., Chapelier A., Hervé P., Prevention of ischemia-reperfusion lung injury by sulfated Lewisa pentasaccharide. Journal of Applied Physiology 1997 82 4 1058 1063 2-s2.0-0030982885
12. Feldman L. J., Himbert D., Juliard J. M., Karrillon G. J., Benamer H., Aubry P., Boudvillain O., Seknadji P., Faraggi M., Steg P. G., Reperfusion syndrome: relationship of coronary blood flow reserve to left ventricular function and infarct size. Journal of the American College of Cardiology 2000 35 5 1162 1169 2-s2.0-0034039687 10.1016/S0735-1097(00)00523-4
13. Hu P., Luo G. A., Zhao Z. Z., Jiang Z. H., Quantitative determination of four diterpenoids in radix Salviae miltiorrhizae using LC-MS-MS. Chemical and Pharmaceutical Bulletin 2005 53 6 705 709 2-s2.0-21144444351 10.1248/cpb.53.705
14. Han J. Y., Fan J. Y., Horie Y., Miura S., Cui D. H., Ishii H., Hibi T., Tsuneki H., Kimura I., Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion. Pharmacology and Therapeutics 2008 117 2 280 295 2-s2.0-38349123913 10.1016/j.pharmthera.2007.09.008
15. Ho J. H. C., Hong C. Y., Salvianolic acids: small compounds with multiple mechanisms for cardiovascular protection. Journal of Biomedical Science 2011 18 1, article 30 2-s2.0-79955776388 10.1186/1423-0127-18-30
16. Jia Y., Huang F., Zhang S., Leung S. W., Is danshen (Salvia miltiorrhiza) dripping pill more effective than isosorbide dinitrate in treating angina pectoris? A systematic review of randomized controlled trials. International Journal of Cardiology 2012 157 3 330 340 2-s2.0-78651382664 10.1016/j.ijcard. 2010.12.073
17. Shi Z. X., Li G., Comparative analysis on the major constituents in radix Salvia miltiorrhizae injectable preparations. China Pharmacy 2009 20 3 207 209
18. Luo W. B., Dong L., Wang Y. P., Effect of magnesium lithospermate B on calcium and nitric oxide in endothelial cells upon hypoxia/reoxygenation. Acta Pharmacologica Sinica 2002 23 10 930 936 2-s2.0-0036790634
19. Sun L. Q., Zhao J., Zhang T. T., Protective effects of salvianolic acid B on schwann cells apoptosis induced by high glucose. Neurochemical Research 2012 37 5 996 1010 10.1007/s11064-011-0695-8
20. Zhang H. S., Wang S. Q., Salvianolic acid B from Salvia miltiorrhiza inhibits tumor necrosis factor- α (TNF- α)-induced MMP-2 upregulation in human aortic smooth muscle cells via suppression of NAD(P)H oxidase-derived reactive oxygen species. Journal of Molecular and Cellular Cardiology 2006 41 1 138 148 2-s2.0-33745345186 10.1016/j.yjmcc.2006.03.007
21. Liu C. S., Cheng Y., Hu J. F., Zhang W., Chen N. H., Zhang J. T., Comparison of antioxidant activities between salvianolic acid B and Ginkgo biloba extract (EGb 761). Acta Pharmacologica Sinica 2006 27 9 1137 1145 2-s2.0-33748799389 10.1111/j.1745-7254.2006.00378.x
22. Zhao G. R., Zhang H. M., Ye T. X., Xiang Z. J., Yuan Y. J., Guo Z. X., Zhao L. B., Characterization of the radical scavenging and antioxidant activities of danshensu and salvianolic acid B. Food and Chemical Toxicology 2008 46 1 73 81 2-s2.0-36848999824 10.1016/j.fct.2007.06.034
23. Ma C., Yao Y., Yue Q. X., Zhou X. W., Yang P. Y., Wu W. Y., Guan S. H., Jiang B. H., Yang M., Liu X., Guo D. A., Differential proteomic analysis of platelets suggested possible signal cascades network in platelets treated with salvianolic acid B. PLoS ONE 2011 6 2 2-s2.0-79951883850 10.1371/journal.pone. 0014692 e14692
24. Mu X. Y., Influence of salvianolate to platelet aggregation and MMP-9 of patients with unstable angina. Chinese Medical Herald 2009 24 59 60
25. Radomski M. W., Palmer R. M. J., Moncade S., An L-arginie nitric oxide pathway present in human platelets regulates aggregation. Proceedings of the National Academy of Sciences of the United States of America 1990 87 13 5193 5197 10.1073/pnas.87.13.5193
26. Radomski M. W., Palmer R. M. J., Moncada S., Characterization of the L-arginine: nitric oxide pathway in human platelets. British Journal of Pharmacology 1990 101 2 325 328 2-s2.0-0025131570
27. Freedman J. E., Loscalzo J., Barnard M. R., Alpert C., Keaney J. F., Michelson A. D., Nitric oxide released from activated platelets inhibits platelet recruitment. The Journal of Clinical Investigation 1997 100 2 350 356 2-s2.0-0030853312
28. Li M., Zhao C., Wong R. N. S., Goto S., Wang Z., Liao F., Inhibition of shear-induced platelet aggregation in rat by tetramethylpyrazine and salvianolic acid B. Clinical Hemorheology and Microcirculation 2004 31 2 97 103 2-s2.0-4644325763
29. Wu Y. P., Zhao X. M., Pan S. D., Guo D. A., Wei R., Han J. J., Kainoh M., Xia Z. L., de Groot P. G., Lisman T., Salvianolic Acid B inhibits platelet adhesion under conditions of flow by a mechanism involving the collagen receptor α 2 β 1. Thrombosis Research 2008 123 2 298 305 2-s2.0-55549097424 10.1016/j.thromres.2008.05.020
30. Lay I. S., Chiu J. H., Shiao M. S., Lui W. Y., Wu C. W., Crude extract of Salvia miltiorrhiza and salvianolic acid B enhance in vitro angiogenesis in murine SVR endothelial cell line. Planta Medica 2003 69 1 26 32 2-s2.0-0037286198 10.1055/s-2003-37034
31. Lee B. W., Chun S. W., Kim S. H., Lee Y., Kang E. S., Cha B. S., Lee H. C., Lithospermic acid B protects beta-cells from cytokine-induced apoptosis by alleviating apoptotic pathways and activating anti-apoptotic pathways of Nrf2-HO-1 and Sirt1. Toxicology and Applied Pharmacology 2011 252 1 47 54 2-s2.0-79952617737 10.1016/j.taap.2011.01.018
32. 2 in vascular smooth muscle cells: potential involvement in vascular disease. International journal of molecular medicine 2003 11 2 229 234 2-s2.0-0042703386
33. Liu C. L., Xie L. X., Li M., Durairajan S. S. K., Goto S., Huang J. D., Salvianolic acid B inhibits hydrogen peroxide-induced endothelial cell apoptosis through regulating PI3K/Akt signaling. PLoS ONE 2007 2 12 2-s2.0-44449179744 10.1371/journal.pone.0001321 e1321
34. Du C. S., Yang R. F., Song S. W., Wang Y. P., Magnesium lithospermate B protects cardiomyocytes from ischemic injury via inhibition of TAB1-p38 apoptosis signaling. Frontiers in Pharmacology 2010 1 111 10.3389/fphar.2010. 00111
35. Xu L. L., Deng Y. P., Feng L. X., Cardio protection of salvianolic acid B through inhibition of apoptosis network. PLoS ONE 2011 6 9 e24036 10.1371/journal.pone.0024036
36. Han X., Liu J. X., Li X. Z., Salvianolic acid B inhibits autophagy and protects starving cardiac myocytes. Acta Pharmacologica Sinica 2011 32 1 38 44 2-s2.0-78651091035 10.1038/aps.2010.182
37. Tang M., Zhang J., Prostate apoptosis response-4 involved in the protective effect of salvianolic acid B against amyloid β peptide-induced damage in PC12 cells. Japanese Journal of Pharmacology 2002 88 4 422 427 2-s2.0-0035985281 10.1254/jjp.88.422
38. Liu X., Chen R., Shang Y., Jiao B., Huang C., Superoxide radicals scavenging and xanthine oxidase inhibitory activity of magnesium lithospermate B from Salvia miltiorrhiza. Journal of Enzyme Inhibition and Medicinal Chemistry 2009 24 3 663 668 2-s2.0-70749090755 10.1080/14756360802323829
39. Hung H. H., Chen Y. L., Lin S. J., Yang S. P., Shih C. C., Shiao M. S., Chang C. H., A salvianolic acid B-rich fraction of Salvia miltiorrhiza induces neointimal cell apoptosis in rabbit angioplasty model. Histology and Histopathology 2001 16 1 175 183 2-s2.0-0035155504
40. Yang J., Zhang G., Tian J., Li C., Jiang W., Xing Y., Zhu H., Hou J., Xu H., Wu J., Cardioprotective effect of SMND-309, a novel derivate of salvianolic acid B on acute myocardial infarction in rats. Basic and Clinical Pharmacology and Toxicology 2010 106 4 317 323 2-s2.0-77949432290 10.1111/j.1742-7843.2009. 00490.x
41. Wang W., Hu G. Y., Wang Y. P., Selective modulation of L-type calcium current by magnesium lithospermate B in guinea-pig ventricular myocytes. Life Sciences 2006 78 26 2989 2997 2-s2.0-33744986009 10.1016/j.lfs.2005.11.024
42. Pan C., Lou L., Huo Y., Singh G., Chen M., Zhang D., Wu A., Zhao M., Wang S., Li J., Salvianolic acid B and Tanshinone IIA attenuate myocardial ischemia injury in mice by no production through multiple pathways. Therapeutic Advances in Cardiovascular Disease 2011 5 2 99 111 2-s2.0-79956024633 10.1177/1753944710396538
43. Wang J., Zhang Y., Guo L. L., Salvianolic acid B inhibits the TLR4-NF B-TNF α pathway and attenuates neonatal rat cardiomyocyte injury induced by lipopolysaccharide. Chinese Journal of Integrative Medicine 2011 17 10 775 779 10.1007/s11655-011-0877-x
44. He H., Shi M., Zeng X., Yang J., Li Y., Wu L., Li L., Cardioprotective effect of salvianolic acid B on large myocardial infarction mediated by reversing upregulation of leptin, endothelin pathways, and abnormal expression of SERCA2a, phospholamban in rats. Journal of Ethnopharmacology 2008 118 1 35 45 2-s2.0-44349177410 10.1016/j.jep.2008.03.006
45. Yang L. M., Xiao Y. L., Ou-Yang J. H., Inhibition of magnesium lithospermate B on the c-Jun N-terminal kinase 3 mRNA expression in cardiomyocytes encountered ischemia/reperfusion injury. Acta Pharmaceutica Sinica 2003 38 7 487 491 2-s2.0-2342632649
46. Chang C. Z., Wu S. C., Kwan A. L., Magnesium lithospermate B alleviates the production of endothelin-1 through an NO-dependent mechanism and reduces experimental vasospasm in rats. Acta Neurochirurgica 2011 153 11 2211 2217 10.1007/s00701-011-1082-6
47. Chen Y. H., Lin S. J., Ku H. H., Shiao M. S., Lin F. Y., Chen J. W., Chen Y. L., Salvianolic acid B attenuates VCAM-1 and ICAM-1 expression in TNF- α -treated human aortic endothelial cells. Journal of Cellular Biochemistry 2001 82 3 512 521 2-s2.0-0034905011 10.1002/jcb.1176
48. Kim S. H., Kim S. H., Choi M., Lee Y., Kim Y. O., Ahn D. S., Kim Y. H., Kang E. S., Lee E. J., Jung M., Cho J. W., Williams D. R., Lee H. C., Natural therapeutic magnesium lithospermate B potently protects the endothelium from hyperglycaemia-induced dysfunction. Cardiovascular Research 2010 87 4 713 722 2-s2.0-77955275051 10.1093/cvr/cvq089
49. Zhou Z., Liu Y., Miao A. D., Wang S. Q., Salvianolic acid B attenuates plasminogen activator inhibitor type 1 production in TNF- α treated human umbilical vein endothelial cells. Journal of Cellular Biochemistry 2005 96 1 109 116 2-s2.0-26444537115 10.1002/jcb.20567
50. Wu H. L., Li Y. H., Lin Y. H., Wang R., Li Y. B., Tie L., Song Q. L., Guo D. A., Yu H. M., Li X. J., Salvianolic acid B protects human endothelial cells from oxidative stress damage: a possible protective role of glucose-regulated protein 78 induction. Cardiovascular Research 2009 81 1 148 158 2-s2.0-57749210168 10.1093/cvr/cvn262
51. Yang Q., Wang S., Xie Y., Wang J., Li H., Zhou X., Liu W., Effect of Salvianolic acid b and paeonol on blood lipid metabolism and hemorrheology in myocardial schemia rabbits induced by pituitruin. International Journal of Molecular Sciences 2010 11 10 3696 3704 2-s2.0-77958133960 10.3390/ijms11103696
52. Shi C. S., Huang H. C., Wu H. L., Kuo C. H., Chang B. I., Shiao M. S., Shi G. Y., Salvianolic acid B modulates hemostasis properties of human umbilical vein endothelial cells. Thrombosis Research 2007 119 6 769 775 2-s2.0-33947302110 10.1016/j.thromres.2006.06.008
53. Wang F., Liu Y. Y., Liu L. Y., Zeng Q. J., Wang C. S., Sun K., Yang J. Y., Guo J., Fan J. Y., Han J. Y., The attenuation effect of 3,4-dihydroxy-phenyl lactic acid and salvianolic acid B on venular thrombosis induced in rat mesentery by photochemical reaction. Clinical Hemorheology and Microcirculation 2009 42 1 7 18 2-s2.0-67651165447 10.3233/CH-2009-1180
54. Zhang H. F., Chen X. Q., Hu G. Y., Wang Y. P., Magnesium lithospermate B dilates mesenteric arteries by activating BK Ca currents and contracts arteries by inhibiting KV currents. Acta Pharmacologica Sinica 2010 31 6 665 670 2-s2.0-77953263676 10.1038/aps.2010.40
55. Lam F. F. Y., Seto S. W., Kwan Y. W., Yeung J. H. K., Chan P., Activation of the iberiotoxin-sensitive BKCa channels by salvianolic acid B of the porcine coronary artery smooth muscle cells. European Journal of Pharmacology 2006 546 1-3 28 35 2-s2.0-33748291559 10.1016/j.ejphar.2006.07.038
56. 2+ level in SH-SY5Y cells. Acta Pharmacologica Sinica 2010 31 8 923 929 2-s2.0-77955447202 10.1038/aps.2010.102
57. Wang W., Hu G. Y., Wang Y. P., Selective modulation of L-type calcium current by magnesium lithospermate B in guinea-pig ventricular myocytes. Life Sciences 2006 78 26 2989 2997 2-s2.0-33744986009 10.1016/j.lfs.2005.11.024
58. Lam F. F. Y., Yeung J. H. K., Kwan Y. W., Chan K. M., Or P. M. Y., Salvianolic acid B, an aqueous component of danshen (Salvia miltiorrhiza), relaxes rat coronary artery by inhibition of calcium channels. European Journal of Pharmacology 2006 553 1-3 240 245 2-s2.0-33751165448 10.1016/j.ejphar.2006. 09.030
59. Jang S. I., Kim H. J., Kim Y. J., Jeong S. I., You Y. O., Tanshinone IIA inhibits LPS-induced NF- B activation in RAW 264.7 cells: possible involvement of the NIK-IKK, ERK1/2, p38 and JNK pathways. European Journal of Pharmacology 2006 542 1-3 1 7 2-s2.0-33745997334 10.1016/j.ejphar.2006.04.044
60. Jang S. I., Jeong S. I., Kim K. J., Kim H. J., Yu H. H., Park R., Kim H. M., You Y. O., Tanshinone IIA from salvia miltiorrhiza inhibits inducible nitric oxide synthase expression and production of TNF- α IL-1 β and IL-6 in activated RAW 264.7 cells. Planta Medica 2003 69 11 1057 1059 2-s2.0-0346059348 10.1055/s-2003-45157
61. Sun A. J., Liu H. Y., Wang S. J., Salvianolic acid B suppresses maturation of human monocyte-derived dendritic cells by activating PPAR γ British Journal of Pharmacology 2011 164 8 2042 2053 10.1111/j.1476-5381.2011. 01518.x
62. Chung C. S., Lin Y. L., Huang B., Salvianolic acid B suppresses IFN- γ -induced JAK/STAT1 activation in endothelial cells. Thrombosis Research 2011 128 6 560 564 10.1016/j.thromres.2011.08.032
63. Wang S. X., Hu L. M., Gao X. M., Guo H., Fan G. W., Anti-inflammatory activity of salvianolic acid B in microglia contributes to its neuroprotective effect. Neurochemical Research 2010 35 7 1029 1037 2-s2.0-77953197744 10.1007/s11064-010-0151-1
64. Cheng C. C., Yang S. P., Lin W. S., Magnesium lithospermate B mediates anti-inflammation targeting activator protein-1 and nuclear factor- B signaling pathways in human peripheral T lymphocytes. International Immunopharmacology 2012 13 3 354 361 10.1016/j.intimp.2012.04.011
65. Chen T., Liu W., Chao X., Zhang L., Qu Y., Huo J., Fei Z., Salvianolic acid B attenuates brain damage and inflammation after traumatic brain injury in mice. Brain Research Bulletin 2011 84 2 163 168 2-s2.0-79451471769 10.1016/j.brainresbull.2010.11.015
66. Chen Y. L., Hu C. S., Lin F. Y., Chen Y. H., Sheu L. M., Ku H. H., Shiao M. S., Chen J. W., Lin S. J., Salvianolic acid B attenuates cyclooxygenase-2 expression in vitro in LPS-treated human aortic smooth muscle cells and in vivo in the apolipoprotein-E-deficient mouse aorta. Journal of Cellular Biochemistry 2006 98 3 618 631 2-s2.0-33646567844 10.1002/jcb.20793
67. Xie L. X., Durairajan S. S. K., Lu J. H., Liu C. L., Kum W. F., Wang Y., Koo I., Wu W. K., Han D., Lao F., Huang J. D., Li M., The effect of salvianolic acid B combined with laminar shear stress on TNF- α -stimulated adhesion molecule expression in human aortic endothelial cells. Clinical Hemorheology and Microcirculation 2010 44 4 245 258 2-s2.0-77954100567 10.3233/CH-2010-1269
68. Hur K. Y., Seo H. J., Kang E. S., Kim S. H., Song S., Kim E. H., Lim S., Choi C., Heo J. H., Hwang K. C., Ahn C. W., Cha B. S., Jung M., Lee H. C., Therapeutic effect of magnesium lithospermate B on neointimal formation after balloon-induced vascular injury. European Journal of Pharmacology 2008 586 1-3 226 233 2-s2.0-43549099498 10.1016/j.ejphar.2008.02.072
69. Pan C. H., Chen C. W., Ming-Jyh S., Salvianolic acid B inhibits SDF-1 α -stimulated cell proliferation and migration of vascular smooth muscle cells by suppressing CXCR4 receptor. Vascular Pharmacology 2012 56 1 98 105 10.1016/j.vph.2011.11.008
70. Luo P., Tan Z., Zhang Z., Li H., Mo Z., Inhibitory effects of salvianolic acid B on the high glucose-induced mesangial proliferation via NF- B-dependent pathway. Biological and Pharmaceutical Bulletin 2008 31 7 1381 1386 2-s2.0-46449095466 10.1248/bpb.31.1381
71. Hur K. Y., Kim S. H., Choi M. A., Williams D. R., Lee Y. H., Kang S. W., Yadav U. C. S., Srivastava S. K., Jung M., Cho J. W., Kim S. G., Kang E. S., Lee E. J., Lee H. C., Protective effects of magnesium lithospermate B against diabetic atherosclerosis via Nrf2-ARE-NQO1 transcriptional pathway. Atherosclerosis 2010 211 1 69 76 2-s2.0-77954314390 10.1016/j.atherosclerosis. 2010.01.035
72. Sun A. J., Liu H. Y., Wang S. J., Salvianolic acid B suppresses maturation of human monocyte-derived dendritic cells by activating PPAR γ British Journal of Pharmacology 2011 164 8 2042 2053 10.1111/j.1476-5381.2011. 01518.x
73. Bao Y., Wang L., Xu Y. N., Salvianolic acid B inhibits macrophage uptake of modified low density lipoprotein (mLDL) in a scavenger receptor CD36-dependent manner. Atherosclerosis 2012 223 1 152 159 10.1016/j. atherosclerosis.2012.05.006
74. Lin S. J., Lee I. T., Chen Y. H., Lin F. Y., Sheu L. M., Ku H. H., Shiao M. S., Chen J. W., Chen Y. L., Salvianolic acid B attenuates MMP-2 and MMP-9 expression in vivo in apolipoprotein-E-deficient mouse aorta and in vitro in LPS-treated human aortic smooth muscle cells. Journal of Cellular Biochemistry 2007 100 2 372 384 2-s2.0-33846443173 10.1002/jcb.21042
75. Wang Y. H., Xu F., Chen J., Matrix metalloproteinase-9 induces cardiac fibroblast migration, collagen and cytokine secretion: inhibition by salvianolic acid B from Salvia miltiorrhiza. Phytomedicine 2011 19 1 13 19 10.1016/j.phymed.2011.06.024
76. Lv Z., Xu L., Salvianolic Acid B inhibits ERK and p38 MAPK signaling in TGF- β 1-stimulated human hepatic stellate cell Line (LX-2) via distinct pathways. Evidence-Based Complementary and Alternative Medicine 2012 2012 11 960128 10.1155/2012/960128
77. Jiang B., Chen J., Xu L., Gao Z., Deng Y., Wang Y., Xu F., Shen X., Guo D. A., Salvianolic acid B functioned as a competitive inhibitor of matrix metalloproteinase-9 and efficiently prevented cardiac remodeling. BMC Pharmacology 2010 10, article 10 2-s2.0-77955793354 10.1186/1471-2210-10-10
78. Tang M. K., Zhang J. T., Salvianolic acid B inhibits fibril formation and neurotoxicity of amyloid beta-protein in vitro. Acta Pharmacologica Sinica 2001 22 4 380 384 2-s2.0-0035049210
79. + current inactivation and increases action potential duration in isolated rat ventricular myocytes. British Journal of Pharmacology 2004 143 6 765 773 2-s2.0-10044297370 10.1038/sj.bjp.0705969
80. Xu H., Chen K. J., Making evidence-based decisions in the clinical practice of integrative medicine. Chinese Journal of Integrative Medicine 2010 16 6 483 485 2-s2.0-79952569703 10.1007/s11655-010-0560-7
81. Chen K. J., Clinical service of Chinese medicine. Chinese Journal of Integrative Medicine 2008 14 3 163 164 2-s2.0-54549099086 10.1007/s11655-008- 0163-8
82. Wang J., Xiong X. J., Current situation and perspectives of clinical study in integrative medicine in China. Evidence-Based Complementary and Alternative Medicine 2012 2012 11 268542 10.1155/2012/268542
83. Wang J., Xiong X. J., Control strategy on hypertension in Chinese medicine. Evidence-Based Complementary and Alternative Medicine 2012 2012 6 284847 10.1155/2012/284847
84. Wang J., Xiong X. J., Outcome measures of Chinese herbal medicine for hypertension: an overview of systematic reviews. Evidence-Based Complementary and Alternative Medicine 2012 2012 7 697237 10.1155/2012/697237
85. Liu M. Y., Chen K. J., Convergence: the tradition and the modern. Chinese Journal of Integrative Medicine 2012 18 3 164 165 10.1007/s11655-012-1014-1
86. Wang J., Wang P. Q., Xiong X. J., Current situation and re-understanding of syndrome and formula syndrome in Chinese medicine. Internal Medicine 2012 2 3 100013 10.4172/2165-8048.1000113
87. Robinson N., Integrative medicine-traditional Chinese medicine, a model? Chinese Journal of Integrative Medicine 2011 17 1 21 25 10.1007/s11655-011-0602- 9
88. Liu Y., Yin H. J., Shi D. Z., Chen K. J., Chinese herb and formulas for promoting blood circulation and removing blood stasis and antiplatelet therapies. Evidence-Based Complementary and Alternative Medicine 2012 2012 184503 10.1155/2012/184503
89. Xu H., Chen K. J., Integrating traditional medicine with biomedicine towards a patient-centered healthcare system. Chinese Journal of Integrative Medicine 2011 17 2 83 84 2-s2.0-79952558248 10.1007/s11655-011-0641-2
90. Chen K. J., Shi D. Z., Xu H., Lü S. Z., Li T. C., Ke Y. N., Zhang M. Z., Lu X. Y., Sun R. Y., You S. J., XS0601 reduces the incidence of restenosis: a prospective study of 335 patients undergoing percutaneous coronary intervention in China. Chinese Medical Journal 2006 119 1 6 13 2-s2.0-33644989276
91. Xu H., Chen K., Integrative medicine: the experience from China. Journal of Alternative and Complementary Medicine 2008 14 1 3 7 2-s2.0-38749126248 10.1089/acm.2006.6329
92. Chen K. J., Where are we going? Chinese Journal of Integrative Medicine 2010 16 2 100 101 2-s2.0-77954528292 10.1007/s11655-010-0100-5
93. Xiong X. J., Chu F. Y., Li H. X., He Q. Y., Clinical application of the TCM classic formulae for treating chronic bronchitis. Journal of Traditional Chinese Medicine 2011 31 1 69 72 2-s2.0-79956160524
94. Xu H., Chen K. J., Complementary and alternative medicine: is it possible to be mainstream. Chinese Journal of Integrative Medicine 2012 18 6 403 404 10.1007/s11655-012-1126-7
95. Keji C., Hao X., The integration of traditional Chinese medicine and western medicine. European Review 2003 11 2 225 235 2-s2.0-0038115317 10.1017/S106279870300022X
96. Xiong X. J., Chu F. Y., Li H. X., He Q. Y., Clinical application of the TCM classic formulae for treating chronic bronchitis. Journal of Traditional Chinese Medicine 2011 31 1 69 72 2-s2.0-79956160524
97. Xiong X. J., Wang J., Discussion of related problems in herbal prescription science based on objective indications of herbs. Journal of Chinese Integrative Medicine 2010 8 1 20 24 2-s2.0-75749134544 10.3736/jcim20100104
98. Xiong X. J., Wang J., Experience of diagnosis and treatment of exogenous high-grade fever. Journal of Chinese Integrative Medicine 2011 9 6 681 687 2-s2.0-79960034059 10. 3736/jcim20110616
99. Wang J., Xiong X. J., Explaining syndromes of decoction for removing blood stasis in chest. Zhongguo Zhong Yao Za Zhi 2011 36 21 3026 3031